Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
How would you approach a triple negative carcinoma of the axilla with unknown primary and a CR after neoadj chemo followed by ALND?
Would you offer RT to the axilla? Would you treat the breast?
Answer from: Radiation Oncologist at Community Practice
Breast plus RNI excluding dissected axilla.
Comments
Radiation Oncologist at Providence Health, St. Joseph Hospital
Could you discuss how you would set up fields to t...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
For RNI, would need a separate field. Treat with t...
4312
4313
Sign in or Register to read more
9761
Related Questions
Would you omit post-lumpectomy radiotherapy for high clinical risk, but low molecular risk DCIS?
What is your preferred sequencing of adjuvant chemotherapy and PMRT for node + breast cancer?
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
When should the dissected axilla (levels I-II) be included when delivering RNI?
How do you advise patients on cardiotoxicity when they are expected to receive a low mean heart dose and low cardiac substructure doses with their radiation plan?
Would you omit radiation for an elderly woman with bilateral breast cancers (both early-stage disease and ER+/PR+/HER2 negative) who otherwise meets the criteria for endocrine therapy alone?
In cT4aN0 triple negative breast cancer would you still recommend PMRT if pCR, ypT0N0(sn), after neoadj chemo is achieved?
When treating early stage breast cancer with adjuvant RT, what risk factors would lead you to include the level 1 and 2 axilla in patients with pN0(i+) disease?
How would you manage a patient with micrometastatic node positive tumor post mastectomy (no neoadjuvant chemotherapy)?
How do your PMRT recommendations change with ITCs after neoadjuvant chemotherapy if they had SLNB only versus ALND in light of B51?
Could you discuss how you would set up fields to t...
For RNI, would need a separate field. Treat with t...